Emergent BioSolutions Announces Appointment of Sujata Dayal to Board of Directors PressReach · Jul 6, 2022
Outlook Therapeutics Announces Full Cash Pre-Payment of Convertible Promissory Note PressReach · Jul 5, 2022
Fulcrum Therapeutics Enrolls First Patient in Pivotal Global Phase 3 Clinical Trial of Losmapimod for Facioscapulohumeral Muscular Dystrophy (FSHD) PressReach · Jul 5, 2022
Evofem Strengthens Phexxi® Intellectual Property with New Composition of Matter Patent From USPTO PressReach · Jun 30, 2022
Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders PressReach · Jun 30, 2022
Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders PressReach · Jun 30, 2022
Publication Highlights Potential Clinical Applications of the HTG Transcriptome Panel in Bladder Cancer PressReach · Jun 29, 2022
Evofem Reaches Agreement with One of the Largest Pharmacy Benefit Managers in the U.S. for Access to Phexxi® PressReach · Jun 28, 2022
Hillstream BioPharma Announces Collaboration with Sapien Biosciences in Cancer Treatments PressReach · Jun 27, 2022
Tonix Pharmaceuticals Announces Trial Design of New Phase 2 Clinical Study of TNX-1300 for Cocaine Intoxication PressReach · Jun 27, 2022
